Qiagen NV reported $126.82M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Alaunos Therapeutics USD -7843000 633K Dec/2023
argenx SE USD 286.9M 84.54M Jun/2025
Avita Medical USD -11570000 22.42M Dec/2024
Dianthus Therapeutics USD -31629000 3.19M Jun/2025
Ionis Pharmaceuticals USD 124M 271M Jun/2025
IQVIA Holdings USD 322M 1000K Jun/2025
Moderna USD -818000000 146M Jun/2025
Organon & Co 229M 128M Jun/2025
Qiagen NV USD 126.82M 7.27M Jun/2025
Revvity USD 171.65M 119.26M Jun/2025
Tectonic Therapeutic USD -19010000 1.29M Jun/2025
Viatris USD -217100000 2.88B Jun/2025
Xeris Pharmaceuticals USD -1930000 3.18M Jun/2025